Loss of Estrogen Receptor in Kidney Cells May Cause Preeclampsia and Kidney Issues

New research highlights how loss of estrogen receptor in kidney cells may increase the risk of preeclampsia and long-term kidney problems during and after pregnancy.
Recent research led by scientists from the University of Florence has shed light on how estrogen signaling plays a crucial role in kidney health during pregnancy. The study found that estrogen regulates kidney progenitor cells, which are vital for maintaining healthy kidney function and adapting to the increased demands of pregnancy. In mice with a loss of estrogen receptor alpha (ERα) specifically in renal progenitor cells, researchers observed a failure to support podocyte generation—cells essential for filtering blood in the kidneys—leading to pregnancy complications such as preeclampsia. These mice developed hypertension, proteinuria, and impaired kidney function, conditions mimicking human preeclampsia.
The study employed advanced techniques, including lineage tracing and single-cell RNA sequencing, to understand the female-specific expansion of renal progenitors and podocytes during puberty and pregnancy. Human tissue analysis confirmed that estrogen, mainly acting through ERα, promotes the growth and maturation of renal progenitors. Women with higher progenitor and podocyte counts showed better kidney resilience, whereas those with reduced ERα signaling were more prone to kidney injury.
The findings suggest that proper estrogen signaling supports kidney health by expanding progenitor pools and ensuring adequate filtration capacity during reproductive years. Disruption of this process contributes to pregnancy-related hypertensive disorders, postpartum kidney disease, and long-term health risks for both mother and child, including increased susceptibility to hypertension and chronic kidney disease. The research emphasizes the importance of estrogen receptor function for kidney resilience and highlights potential targets for preventing pregnancy complications and future kidney disease.
source: https://medicalxpress.com/news/2025-09-estrogen-receptor-loss-kidney-cells.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Osteoarthritis Management: Bridging the Gap Between Evidence-Based Guidelines and Real-World Practices
Recent research highlights a significant gap between osteoarthritis treatment guidelines and real-world practices, emphasizing the need for better adherence to evidence-based interventions like weight management and patient education.
Link Between Anxiety and Dizziness in Vestibular Schwannoma Patients
A recent study reveals a strong link between anxiety and increased dizziness in patients with vestibular schwannoma, highlighting the importance of mental health assessment for better symptom management.
Inactivating Key Pathways Enhances Immune Response Against Cancer
Disabling specific genes like CDK12 and CDK13 can activate immune pathways, improve T cell responses, and enhance the effectiveness of cancer immunotherapy efforts, offering new hope for overcoming treatment resistance.
Innovative Brain-Computer Interface Enables Real-Time Voice Synthesis for ALS Patients
UC Davis researchers have developed a cutting-edge brain-computer interface that enables ALS patients to speak in real time by translating brain signals into audible speech, offering new hope for those with speech loss.



